TG THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 51093000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c83c5c1a-9913-4ce6-a9b2-a61f3d7576b1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-24-006144Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/accounts-receivable/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c83c5c1a-9913-4ce6-a9b2-a61f3d7576b1
History
- no predecessors — first report